Updated: May 21, 2021 10:29:11 pm
PIMPRI-CHINCHWAD HAS now recorded 12 deaths related to mucormycosis. The civic-run YCMH, a dedicated Covid hospital, has set up two wards with a capacity of 60 beds to accommodate mucormycosis patients. At present, the hospital has 35 such patients.
Dr Rajendra Wable, dean of YCMH, said so far they had registered 12 deaths.
“Some of these deaths are of those who got mucormycosis while they had Covid-19 and some were afflicted by mucormycosis. Therefore, these are Covid plus mucormycosis deaths,” he said, adding that at least three patients lost vision in one eye.
Dr Aniket Lathi, who heads the ENT (ear, nose throat) department, said, “The team of doctors at YCM hospital has performed 36 surgeries on patients affected with mucormycosis. However, none died after surgery. Two patients who did had Covid plus pneumonia.”
Dr Wable said there was shortage of medicine required to treat mucormycosis. “However, the district collectorate has now taken over the distribution of the injection. They have sought details and our requirements. We have provided the information and are expecting to get the injection,” he said, adding that they were expecting the stock latest by tomorrow.
Dr Wable also said three teams were involved in treating mucormycosis patients. “The doctors who treat patients are from ENT, ophthalmology and dental,” he said, adding that patients were coming to the hospital not only from across Pimpri-Chinchwad, but also from outside civic limits.
Mayor Usha Dhore has directed the civic administration to monitor post-Covid health of patients and quickly admit them to YCMH if they showed signs of black fungus.
Corporator Seema Savale of the BJP, who had earlier demanded a concrete plan to treat mucormycosis, has now urged the administration to formulate a plan for treating “white fungus” or candida cases.
📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines
- The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.